1-3 of 3
Pamela S. Becker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia

Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J. Martins, Brenda Loera, Quy H. Nguyen, Melanie L. Oakes, Bahar Tercan, Boris Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J. Monnat, Jr, Ilya Shmulevich, Pamela S. Becker
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (12): 2659–2671.
https://doi.org/10.1158/1078-0432.CCR-23-1674
Published: 14 June 2024
View article titled, Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
Open the PDF for Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Amer M. Zeidan, Maya Ridinger, Tara L. Lin, Pamela S. Becker, Gary J. Schiller, Prapti A. Patel, Alexander I. Spira, Michaela L. Tsai, Errin Samuëlsz, Sandra L. Silberman, Mark Erlander, Eunice S. Wang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (23): 6132–6140.
https://doi.org/10.1158/1078-0432.CCR-20-2586
Published: 01 December 2020
View article titled, A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Open the PDF for A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma

Irene M. Ghobrial, Chia-Jen Liu, Robert A. Redd, Raymond P. Perez, Rachid Baz, Oksana Zavidij, Romanos Sklavenitis-Pistofidis, Paul G. Richardson, Kenneth C. Anderson, Jacob Laubach, Patrick Henrick, Alexandra Savell, Kaitlen Reyes, Kalvis Hornburg, Stacey Chuma, Peter Sabbatini, Michael D. Robbins, Pamela S. Becker
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 344–353.
https://doi.org/10.1158/1078-0432.CCR-19-0647
Published: 15 January 2020
View article titled, A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Open the PDF for A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma in another window
Includes: Supplementary data